This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Formal, S B Articles by Baron, L S Search for Related Content PubMed PubMed Citation Articles by Formal, S B Articles by Baron, L S

 Previous Article  |  Next Article 

Infect Immun. 1984 November; 46(2): 465-469

Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen.

ABSTRACT

A living oral vaccine, designed to protect against Shigella flexneri 2a infections, was constructed by using Escherichia coli K-12 as a carrier strain. The hybrid strain, designated EC104, contained both chromosomal and plasmid genes from S. flexneri donor strains. In addition to expressing the S. flexneri 2a somatic antigen, it had inherited the property of epithelial-cell invasion. After the oral administration to rhesus monkeys, EC104 was isolated from the feces for up to 3 days, but by day 4 all stool cultures were negative. The serum antibody response against S. flexneri 2a somatic antigen was variable, but the vaccine conferred significant protection against an oral challenge with virulent S. flexneri 2a.

This article has been cited by other articles:

• Noriega, F. R., Liao, F. M., Maneval, D. R., Ren, S., Formal, S. B., Levine, M. M. (1999). Strategy for Cross-Protection among Shigella flexneri Serotypes. Infect. Immun. 67: 782-788 [Abstract] [Full Text]